Cambrex Corporation.
CBM.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Cambrex Corporation is a global contract development and manufacturing organization (CDMO) that provides a range of services and products to the pharmaceutical, biotechnology, and generic drug industries. The company specializes in active pharmaceutical ingredients (APIs), advanced intermediates, an...Show More
Better Health for All
-40
Cambrex received an FDA warning letter in August 2023 concerning issues with data collection and maintenance at its Milan, Italy facility.
1
This indicates a lack of compliance with FDA standards regarding data management, suggesting vulnerabilities in its basic data protection practices.
Fair Money & Economic Opportunity
0
Cambrex Corporation is a contract development and manufacturing organization (CDMO) for the pharmaceutical industry. Its core business, as evidenced by the provided articles detailing investments in drug development and manufacturing capacity, does not involve offering lending, deposit, or other financial services to consumers or underserved communities. Therefore, all KPIs related to "Fair Money & Economic Opportunity" are not applicable to the company's operations.
Fair Pay & Worker Respect
0
No company-wide quantitative data was found for any of the KPIs related to Fair Pay & Worker Respect. The provided articles contain data specific to individual subsidiaries, such as Cambrex Karlskoga AB
1
or Cambrex Charles City, Inc.,
2
or are based on aggregated employee reviews without explicit company-wide scope or the specific metrics required by the rubric. For instance, while some articles mention employee benefits or safety incidents, they do not provide company-wide percentages for health insurance coverage, living wage coverage, or a global Total Recordable Incident Rate (TRIR). Similarly, pay equity ratios, CEO-median pay ratios, collective bargaining share, worker engagement scores, voluntary turnover rates, and insecure contract shares are either qualitative, subsidiary-specific, or not explicitly provided as quantitative, company-wide metrics. Substantiated labor violation incidents for subsidiaries were outside the past three years.
3
Fair Trade & Ethical Sourcing
-30
Cambrex conducts supplier evaluations based on criticality, with frequencies ranging from two to five years.
1
In 2024, 85% of suppliers responded to requests to sign up to Cambrex's global Supplier Code of Conduct, which was implemented in January 2022.
2
,
3
This Code of Conduct serves as an ethical clause, requiring suppliers to operate in full compliance with applicable laws and regulations, and where local laws are less stringent, Cambrex’s principles must be followed.
4
Failure to comply with the Code of Conduct may result in the termination of supply agreements.
5
Honest & Fair Business
0
Cambrex received an EcoVadis score of 66/100 in 2023.
1
The company maintains a comprehensive anti-corruption policy, complying with the Foreign Corrupt Practices Act (FCPA), and implements a systematic procurement process with multi-level approvals to prevent bribery and corruption.
2
All employees are subject to a mandatory ethics policy, and procurement staff receive annual updates on relevant policies.
3
Cambrex also has a comprehensive whistleblower policy, applicable to current and former employees, applicants, consultants, and suppliers, which includes an anonymous reporting channel and protection against reprisal.
4
The policy covers various misconducts, including bribery and corruption, and commits to providing feedback on measures taken within three months of a report.
5
In 2024, no cases were reported to the whistleblowing channel.
6
Kind to Animals
0
No specific, concrete evidence was found in the provided articles regarding Cambrex Corporation's performance on any of the 'Kind to Animals' KPIs. Information on cruelty-free certifications, alternative testing methods, humane certifications for operations, measurable wildlife conservation impact, ethical input substitution, animal welfare supplier audits, cage-free sourcing, animal testing policy or volume, innovation investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaboration, or public policy engagement related to animal welfare was not available. While Article 0 mentions 'animal pharmacology and toxicology studies' as an FDA requirement for IND submissions
1
, this refers to regulatory mandates rather than Cambrex's specific policy, volume, or use of alternatives.
No War, No Weapons
0
No evidence was found in the provided articles to assess Cambrex Corporation against the 'No War, No Weapons' ethical value. The articles do not contain specific data points regarding revenue from arms contracts, dual-use technologies, sales to embargoed regimes, peacebuilding investments, conflict divestment policies, board oversight of defense activities, export end-user certificates, lobbying related to arms control, humanitarian procurement compliance, human rights due diligence in conflict areas, Arms Trade Treaty compliance, AI military safeguards, UN Guiding Principles alignment, dual-use screening, surveillance transparency, ethical red lines for weapons, exposure to controversial weapons, war-risk audit results, annual conflict partner reviews, defense divestment, conflict minerals, peace tech investment, procurement from conflict zones, or ethical red lines compliance rates related to war or weapons.
Planet-Friendly Business
0
While Cambrex's sustainability program reported a 20% reduction in Scope 1 and Scope 2 emissions, the articles do not provide the total absolute Scope 1, 2, and 3 greenhouse gas emissions in tCO₂e, nor a baseline year for the reduction, which is required to score the 'scope_1_2_3_emissions' KPI.
1
No other specific quantitative data points or verifiable facts were provided across the available articles to score any of the other KPIs in the Planet-Friendly Business category.
Respect for Cultures & Communities
0
No specific, quantitative data points relevant to the 'Respect for Cultures & Communities' KPIs were found in the provided articles. The articles discuss general company information
1
, environmental health and safety practices
2
, career opportunities
3
, and an award for a sustainability program in local high schools
4
, but do not provide evidence for metrics such as formal partnerships with community groups, revenue reinvested in local development, cultural appropriation incidents, cultural impact assessment protocols, local employment ratios, or grievance mechanisms availability.
Safe & Smart Tech
-40
Cambrex Corporation experienced a cyberattack on November 8, 2023.
1
, which led to unauthorized access to systems and the personal information of 2,053 individuals, including names and driver's license information.
2
This incident was disclosed on May 31, 2024.
3
The company states it complies with the General Data Protection Regulation (GDPR) and other applicable laws and regulations.
4
Zero Waste & Sustainable Products
-20
The company has no waste disposal violations mentioned in the provided articles, indicating a clean compliance record.
1